Your browser doesn't support javascript.
loading
An atlas of transcribed enhancers across helper T cell diversity for decoding human diseases.
Oguchi, Akiko; Suzuki, Akari; Komatsu, Shuichiro; Yoshitomi, Hiroyuki; Bhagat, Shruti; Son, Raku; Bonnal, Raoul Jean Pierre; Kojima, Shohei; Koido, Masaru; Takeuchi, Kazuhiro; Myouzen, Keiko; Inoue, Gyo; Hirai, Tomoya; Sano, Hiromi; Takegami, Yujiro; Kanemaru, Ai; Yamaguchi, Itaru; Ishikawa, Yuki; Tanaka, Nao; Hirabayashi, Shigeki; Konishi, Riyo; Sekito, Sho; Inoue, Takahiro; Kere, Juha; Takeda, Shunichi; Takaori-Kondo, Akifumi; Endo, Itaru; Kawaoka, Shinpei; Kawaji, Hideya; Ishigaki, Kazuyoshi; Ueno, Hideki; Hayashizaki, Yoshihide; Pagani, Massimiliano; Carninci, Piero; Yanagita, Motoko; Parrish, Nicholas; Terao, Chikashi; Yamamoto, Kazuhiko; Murakawa, Yasuhiro.
Afiliación
  • Oguchi A; RIKEN-IFOM Joint Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Suzuki A; Institute for the Advanced Study of Human Biology, Kyoto University, Kyoto, Japan.
  • Komatsu S; Department of Nephrology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Yoshitomi H; Laboratory for Autoimmune Diseases, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Bhagat S; RIKEN-IFOM Joint Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Son R; IFOM ETS - the AIRC Institute of Molecular Oncology, Milan, Italy.
  • Bonnal RJP; Institute for the Advanced Study of Human Biology, Kyoto University, Kyoto, Japan.
  • Kojima S; Department of Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Koido M; Institute for the Advanced Study of Human Biology, Kyoto University, Kyoto, Japan.
  • Takeuchi K; RIKEN-IFOM Joint Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Myouzen K; Institute for the Advanced Study of Human Biology, Kyoto University, Kyoto, Japan.
  • Inoue G; Department of Nephrology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Hirai T; IFOM ETS - the AIRC Institute of Molecular Oncology, Milan, Italy.
  • Sano H; Genome Immunobiology RIKEN Hakubi Research Team, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Takegami Y; Division of Molecular Pathology, Department of Cancer Biology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Kanemaru A; Laboratory of Complex Trait Genomics, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.
  • Yamaguchi I; Laboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Ishikawa Y; RIKEN-IFOM Joint Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Tanaka N; Institute for the Advanced Study of Human Biology, Kyoto University, Kyoto, Japan.
  • Hirabayashi S; Department of Medical Systems Genomics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Konishi R; Laboratory for Autoimmune Diseases, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Sekito S; Laboratory for Autoimmune Diseases, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Inoue T; RIKEN-IFOM Joint Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Kere J; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
  • Takeda S; RIKEN-IFOM Joint Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Takaori-Kondo A; K.K. DNAFORM, Yokohama, Japan.
  • Endo I; K.K. DNAFORM, Yokohama, Japan.
  • Kawaoka S; K.K. DNAFORM, Yokohama, Japan.
  • Kawaji H; Laboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Ishigaki K; Laboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Ueno H; RIKEN-IFOM Joint Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Hayashizaki Y; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Pagani M; Division of Precision Medicine, Kyushu University Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Carninci P; Inter-Organ Communication Research Team, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan.
  • Yanagita M; Institute for the Advanced Study of Human Biology, Kyoto University, Kyoto, Japan.
  • Parrish N; Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, Mie University, Tsu, Japan.
  • Terao C; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.
  • Yamamoto K; Stem Cells and Metabolism Research Program, University of Helsinki, Helsinki, Finland.
  • Murakawa Y; Folkhalsan Research Center, Helsinki, Finland.
Science ; 385(6704): eadd8394, 2024 Jul 05.
Article en En | MEDLINE | ID: mdl-38963856
ABSTRACT
Transcribed enhancer maps can reveal nuclear interactions underpinning each cell type and connect specific cell types to diseases. Using a 5' single-cell RNA sequencing approach, we defined transcription start sites of enhancer RNAs and other classes of coding and noncoding RNAs in human CD4+ T cells, revealing cellular heterogeneity and differentiation trajectories. Integration of these datasets with single-cell chromatin profiles showed that active enhancers with bidirectional RNA transcription are highly cell type-specific and that disease heritability is strongly enriched in these enhancers. The resulting cell type-resolved multimodal atlas of bidirectionally transcribed enhancers, which we linked with promoters using fine-scale chromatin contact maps, enabled us to systematically interpret genetic variants associated with a range of immune-mediated diseases.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Transcripción Genética / Linfocitos T CD4-Positivos / Elementos de Facilitación Genéticos / Predisposición Genética a la Enfermedad / Sitio de Iniciación de la Transcripción Límite: Humans Idioma: En Revista: Sci. (N.Y., N.Y.) / Science Año: 2024 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Transcripción Genética / Linfocitos T CD4-Positivos / Elementos de Facilitación Genéticos / Predisposición Genética a la Enfermedad / Sitio de Iniciación de la Transcripción Límite: Humans Idioma: En Revista: Sci. (N.Y., N.Y.) / Science Año: 2024 Tipo del documento: Article País de afiliación: Japón